Pfizer (PFE) total liabilities

Total liabilities · fiscal 2025
$121.39B

Pfizer (PFE) had total liabilities of $121.39B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $124.90B of fiscal 2024. Figures as of 18 Nov 2026, 20:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$121.39B
Change on fiscal 2024
−2.8%
Growth, 5 years
+6.0% a year
Growth, 10 years
+1.7% a year
Highest on record
$137.21Bfiscal 2023
Lowest on record
$53.41Bfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pfizer total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 6.0% a year; over ten years the rate was 1.7% a year. Across the 18 fiscal years on record (2008–2025), the highest was $137.21B in fiscal 2023 and the lowest $53.41B in fiscal 2008.

History · 18 fiscal years

Total liabilities by fiscal year

Pfizer total liabilities, year by year

Pfizer (PFE) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$121.39B 2.8% down
2024$124.90B 9.0% down
2023$137.21B 35.5% up
2022$101.29B 2.6% down
2021$104.01B 14.6% up
2020$90.76B 12.9% down
2019$104.15B 8.9% up
2018$95.66B 4.5% down
2017$100.14B 10.4% down
2016$111.78B 9.2% up
2015$102.38B 6.7% up
2014$95.94B 0.5% up
2013$95.48B 8.3% down
2012$104.12B 1.2% down
2011$105.38B 1.3% down
2010$106.75B 12.9% down
2009$122.50B 129.4% up
2008$53.41B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Pfizer and comparable companies
CompanyTotal liabilitiesFiscal year
Abbott Laboratories ABT$33.94B2025
Novo Nordisk NVODKK 348.86B2025
Pfizer PFE$121.39B2025
Danaher DHR$30.92B2025
Intuitive Surgical ISRG$2.52B2025
Vertex Pharmaceuticals VRTX$6.98B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PFE

Pfizer, figure by figure

Pfizer (PFE) overview: price, valuation and scorecardAll health care companies by market value

Pfizer total liabilities: questions and answers

How large are Pfizer's total liabilities?

Pfizer (PFE) had total liabilities of $121.39B at the end of fiscal 2025 (December 31, 2025). That is 2.8% lower than the $124.90B of fiscal 2024.

What is the growth rate of Pfizer's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 6.0% a year; over ten years the rate was 1.7% a year.

What are the highest and lowest total liabilities figures on record for Pfizer?

Across the 18 fiscal years on record (2008–2025), the highest was $137.21B in fiscal 2023 and the lowest $53.41B in fiscal 2008.

How is Pfizer's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Pfizer it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pfizer (PFE) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/PFE/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.